Bambuterol HCl (Bambec; Oxeol; KWD-2183l; UNII-Y1850G1OVC), the hydrochloride salt of Bambuterol which is a prodrug of terbutaline, is a potent and long acting beta-adrenoceptor agonist (LABA) that was approved (outside the US) for use in the treatment of asthma. Bambuterol functions as a bronchodilator, extending the duration of suxamethonium-induced neuromuscular blockade by inhibiting plasma BChE (cholinesterase) during metabolism.
Physicochemical Properties
| Molecular Formula | C18H30CLN3O5 | |
| Molecular Weight | 403.90 | |
| Exact Mass | 403.187 | |
| Elemental Analysis | C, 40.74; H, 3.65; Br, 18.07; N, 15.84; O, 21.71 | |
| CAS # | 81732-46-9 | |
| Related CAS # | Bambuterol-d9 hydrochloride; 1794810-59-5; Bambuterol; 81732-65-2 | |
| PubChem CID | 54765 | |
| Appearance | White to off-white solid powder | |
| Density | 1.154g/cm3 | |
| Boiling Point | 500.9ºC at 760 mmHg | |
| Melting Point | 222-224ºC | |
| Flash Point | 256.7ºC | |
| Index of Refraction | 1.533 | |
| LogP | 3.421 | |
| Hydrogen Bond Donor Count | 3 | |
| Hydrogen Bond Acceptor Count | 6 | |
| Rotatable Bond Count | 8 | |
| Heavy Atom Count | 27 | |
| Complexity | 446 | |
| Defined Atom Stereocenter Count | 0 | |
| SMILES | Cl.O=C(N(C)C)OC1C=C(C(CNC(C)(C)C)O)C=C(OC(N(C)C)=O)C=1 |
|
| InChi Key | LBARATORRVNNQM-UHFFFAOYSA-N | |
| InChi Code | InChI=1S/C18H29N3O5.ClH/c1-18(2,3)19-11-15(22)12-8-13(25-16(23)20(4)5)10-14(9-12)26-17(24)21(6)7;/h8-10,15,19,22H,11H2,1-7H3;1H | |
| Chemical Name | [3-[2-(tert-butylamino)-1-hydroxyethyl]-5-(dimethylcarbamoyloxy)phenyl] N,N-dimethylcarbamate;hydrochloride | |
| Synonyms |
|
|
| HS Tariff Code | 2934.99.9001 | |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: Please store this product in a sealed and protected environment, avoid exposure to moisture. |
|
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| Targets | beta-adrenoceptor |
| ln Vitro | Bambuterol ((±)-Bambuterol hydrochloride; KWD-2183 hydrochloride) should not be taken by pregnant women or those with severe liver impairment. Renal impairment sufferers can use it, but dose modifications are required. Similar to salbutamol, bambuterol can cause similar adverse effects, such as headache, dizziness, tremor, nausea, and exhaustion. |
| References |
[1]. Bambuterol, From Wikipedia |
| Additional Infomation | Bambuterol hydrochloride is the hydrochloride salt of bambuterol. A long acting beta-adrenoceptor agonist used in the treatment of asthma, it is a prodrug for terbutaline. It has a role as an anti-asthmatic drug, a bronchodilator agent, a prodrug, a beta-adrenergic agonist, a sympathomimetic agent and an EC 3.1.1.7 (acetylcholinesterase) inhibitor. It is a hydrochloride, a carbamate ester and a member of phenylethanolamines. It contains a bambuterol. |
Solubility Data
| Solubility (In Vitro) |
|
|||
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 3 mg/mL (7.43 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 30.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 3 mg/mL (7.43 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 30.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. Solubility in Formulation 3: ≥ 3 mg/mL (7.43 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 30.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly. Solubility in Formulation 4: 50 mg/mL (123.79 mM) in PBS (add these co-solvents sequentially from left to right, and one by one), clear solution; with ultrasonication.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.4759 mL | 12.3793 mL | 24.7586 mL | |
| 5 mM | 0.4952 mL | 2.4759 mL | 4.9517 mL | |
| 10 mM | 0.2476 mL | 1.2379 mL | 2.4759 mL |